News

Scientists from Cincinnati Children's and colleagues based in Japan report achieving a major step forward in organoid technology: producing liver tissue that grows its own internal blood vessels.
The sixth edition of the popular event features 72 teams competing at Midland Country Club for a $3.3 million purse.
The U.S. Intravenous Immunoglobulin Market plays a crucial role in treating immunodeficiency diseases and various autoimmune disorders, reflecting a steady evolution influenced by advanced therapies ...
ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...
This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in ...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.
Rusfertide is an investigational, first-in-class hepcidin mimetic peptide therapeutic that aims to regulate iron homeostasis ...
Jan. 30-Feb. 2 _ Hilton Grand Vacations Tournament of Champions (A Lim Kim) March 27-30 _ Ford Championship presented by Wild Horse Pass (Hyo Joo Kim) April 2-6 _ T-Mobile Match Play presented by MGM ...
1, Mi Hyang Lee, 9. 2 (tie), Yealimi Noh and Madelene Sagstrom, 8. 4 (tie), Rio Takeda and Chanettee Wannasaen, 7. 6, 8 tied with 6. 1, Xiaowen Yin, .67%. 2, Jin Hee Im, .60%. 3 (tie), Madelene ...
CSL's R&D chief says the company's new hereditary angioedema treatment is one of only a few drugs to be built from scratch in ...